Market steady; Teva and Camtek patent cases in focus
March 08, 2009 at 09:26 AM EDT
Israel stocks were little changed on Sunday, led by weakness in Israel Chemicals and offset by a positive move in Teva Pharmaceutical.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.